Search results for "OTHER"

showing 10 items of 12132 documents

Understanding the risks for post-disaster infectious disease outbreaks: a systematic review protocol

2020

Introduction Disasters have many forms, including those related to natural hazards and armed conflict. Human-induced global change, such as climate change, may alter hazard parameters of these disasters. These alterations can have serious consequences for vulnerable populations, which often experience post-disaster infectious disease outbreaks, leading to morbidity and mortality. The risks and drivers for these outbreaks and their ability to form cascades, are somewhat contested. Despite evidence for post-disaster outbreaks, reviews quantifying them have been on short time scales, specific geographic areas or specific hazards. This review aims to fill this gap and gain a greater understandi…

medicine.medical_specialtyprotocols & guidelinesPopulationMEDLINEDisease Outbreaks1117 Public Health and Health ServicesVDP::Medisinske Fag: 700::Helsefag: 800::Ernæring: 811DisastersMeta-Analysis as TopicEnvironmental healthNatural hazardHumansMedicine1506educationRetrospective Studieseducation.field_of_studybusiness.industryPublic healthpublic healthROutbreak1103 Clinical SciencesGeneral Medicine1692ChecklistPeer reviewReview Literature as TopicCross-Sectional StudiesInfectious disease (medical specialty)Medicineepidemiologybusiness1199 Other Medical and Health Sciences
researchProduct

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy

2015

Context: The therapeutic strategy in intermediate risk (IR) non-muscle invasive bladder cancer (NMIBC) recurring after intravesical therapy (IT) is not well defined. Most patients are usually retreated by Bacillus Calmette-Guerin (BCG). Aims: To evaluate the efficacy of intravesical chemotherapy (ICH) given at recurrence after the first cycle of ICH in IR-NMIBC recurring 6 months or later. Settings and Design: Retrospective analysis of the efficacy of ICH given after previous IT. Materials and Methods: The clinical files of IR-NMIBC patients recurring later than 6 months after transurethral resection (TUR) and IT and retreated by IT were reviewed. The patients should be at intermediate risk…

medicine.medical_specialtyrecurrenceUrologyContext (language use)intermediate risklcsh:RC870-923Settore MED/24 - UrologiaCytologyintravesical chemotherapyAdjuvant therapyMedicinecardiovascular diseasesBacillus Calmette-GuerinBladder cancermedicine.diagnostic_testbusiness.industryProportional hazards modelCystoscopylcsh:Diseases of the genitourinary system. Urologymedicine.diseaseSurgerynervous system diseasesBacillus Calmette-Guerin intermediate risk intravesical chemotherapy non muscle invasive bladder cancer recurrenceMann–Whitney U testnon muscle invasive bladder cancerOriginal ArticlebusinessIntravesical chemotherapyUrology Annals
researchProduct

Laparoscopy versus open adrenalectomy in patients with solid tumor metastases: results of a multicenter European study

2020

Background: The outcome of adrenalectomy carried out by laparoscopy or open surgery for solid tumor metastases was assessed. Methods: A total of 317 patients with histologically confirmed adrenal metastatic disease collected from 30 centres in Europe underwent adrenalectomy by laparoscopy (n=146) or open laparotomy (n=171). Differences between laparoscopic and open adrenalectomy were assessed by a single Cox analysis for both procedures. Results: The median overall survival was 24.0 [95% confidence interval (CI): 21.4-26.6] months for open adrenalectomy and 45.0 (95% CI: 22.6-67.4) for laparoscopic adrenalectomy (P=0.008). Survival rates were 68%, 49%, 35% and 29% at 1, 2, 3 and 5 years for…

medicine.medical_specialtyretrospective studymedicine.medical_treatmentUrologysurvivalMetastasis03 medical and health sciences0302 clinical medicineMetàstasiLaparotomymedicineLaparoscopyTumorsChemotherapymedicine.diagnostic_testbusiness.industryAdrenalectomyHazard ratioopen adrenalectomyAdrenalectomyRetrospective cohort studymedicine.diseasePrimary tumorConfidence interval3. Good healthLaparoscòpiaAdrenalectomy; open adrenalectomy; laparoscopic adrenalectomy; survival; retrospective study030220 oncology & carcinogenesisOriginal ArticleLaparoscopy030211 gastroenterology & hepatologySurgerybusinesslaparoscopic adrenalectomyGland Surgery
researchProduct

Salivary gland cancer in Southern Brazil: a prognostic study of 107 cases.

2020

Background Salivary gland cancers (SGC) represent an uncommon group of heterogeneous tumors. We performed a retrospective survey of SGC diagnosed in a reference center for treatment of malignant tumors from the south of Brazil aiming to determine the prognostic value of demographic, clinic and pathologic features. Material and Methods Cases diagnosed as SGC between 2006 and 2016 were retrospectively collected. Medical records were examined to extract demographic, clinic, pathologic and follow-up information. Results One-hundred and seven cases of SGC were identified. The most common SGC were mucoepidermoid carcinoma (MEC) (n = 39) followed by adenoid cystic carcinoma (AdCC) (n = 29). Among …

medicine.medical_specialtysjögren syndromeAdenoid cystic carcinomamedicine.medical_treatmentsalivary glandsPerineural invasionGastroenterologyMucoepidermoid carcinomaInternal medicineOral Cancer and Potentially malignant disordersmedicineHumansIntermediate GradexerostomiaGeneral DentistryUNESCO:CIENCIAS MÉDICASRetrospective StudiesChemotherapySalivary glandbusiness.industryResearchNeck dissectionmedicine.diseasePrognosisSalivary Gland Neoplasmsmedicine.anatomical_structureOtorhinolaryngologySalivary gland cancerSurgeryNeoplasm Recurrence LocalbusinessBrazilMedicina oral, patologia oral y cirugia bucal
researchProduct

Revision of AUDIT Consumption Items to Improve the Screening of Youth Binge Drinking

2017

This study analyzes the appropriateness of an improved version of one of the most frequently used instruments for the screening of high-risk alcohol consumption. This adaptation was created in accordance with certain limitations recognized by other researchers and in an attempt to adjust the content and scales of some items to a more consensual definition of binge drinking. After revising items 2 and 3, the areas under the ROC curves of the AUDIT and of different abbreviated versions were calculated. A total of 906 minors (468 females) between the ages of 15 and 17 were evaluated. Stratified sampling was conducted on a population of high school students in the city of Valencia (Spain). One …

medicine.medical_specialtyunderagealcohol screeningPopulationlcsh:BF1-990030508 substance abuseBinge drinkingAudit03 medical and health sciences0302 clinical medicinemedicineFalse positive paradoxPsychologyROC030212 general & internal medicinePsychiatryeducationGeneral PsychologyOriginal ResearchConsumption (economics)education.field_of_studybinge drinkingTest (assessment)Stratified samplinglcsh:PsychologyAUDIT0305 other medical sciencePsychologyAlcohol consumptionDemographyFrontiers in Psychology
researchProduct

Effects of Home-Based Physical Exercise on Days at Home and Cost-Effectiveness in Pre-Frail and Frail Persons: Randomized Controlled Trial.

2021

Objectives: Frailty increases the risks of hospitalization, institutionalization, and death. Our objective was to study the effects of home-based physical exercise on the number of days spent at home among pre frail and frail persons, versus usual care. In addition, utilization and costs of health care and social services, cost-effectiveness, and health-related quality-of-life (HRQoL) were explored. Design: Randomized controlled trial, with year-long supervised exercise for 60 minutes twice a week versus usual care. Follow-up for 24 months after randomization. Setting and Participants: A sample of 299 home-dwelling persons in South Karelia, Finland. Main inclusion criteria: >65 years, meeti…

medicine.medical_specialtyutilization of social and healthcare servicesterveyspalvelutCost effectivenesssosiaalipalvelutCost-Benefit AnalysisFrail ElderlykotihoitovanhuksetPhysical exercisefrailtyliikuntaRate ratiolaitoshoitolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawHealth caremedicineHumans030212 general & internal medicineExerciseGeneral NursingFinlandAgedAged 80 and overInpatient careexercise cost-effectivenessFrailtybusiness.industryHealth PolicyMedical recordkustannustehokkuusGeneral MedicineConfidence interval3. Good health3121 General medicine internal medicine and other clinical medicinePhysical therapyQuality of LifeFemaleGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryikääntyneetfyysinen aktiivisuusJournal of the American Medical Directors Association
researchProduct

Validity and Reliability of the Finnish Version of the Locomotor Capabilities Index-5 in Patients Fitted with a Prosthesis after Major Lower Extremit…

2019

medicine.medical_specialtyvalidityIndex (economics)medicine.medical_treatmentLower extremity amputationBiomedical EngineeringValidityProsthesis03 medical and health sciences0302 clinical medicinekyvykkyysSuomimedicinecapabilitiesOrthopedics and Sports MedicineIn patient030212 general & internal medicineta315ta316proteesitreliabilitybusiness.industrycapability030503 health policy & servicesRehabilitationamputaatiolocomotorFinnishtranstibial amputationLocomotor Capabilities IndexLCIvaliditeettiPhysical therapy0305 other medical sciencebusinessluotettavuusJournal of Prosthetics and Orthotics
researchProduct

Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration

2018

PurposeThe ThRombolysis in Ischemic Stroke Patients (TRISP) collaboration aims to address clinically relevant questions about safety and outcomes of intravenous thrombolysis (IVT) and endovascular thrombectomy. The findings can provide observational information on treatment of patients derived from everyday clinical practice.ParticipantsTRISP is an open, investigator-driven collaborative research initiative of European stroke centres with expertise in treatment with revascularisation therapies and maintenance of hospital-based registries. All participating centres made a commitment to prospectively collect data on consecutive patients with stroke treated with IVT using standardised definiti…

medicine.medical_treatment2700 General Medicineregistry030204 cardiovascular system & hematologyRECOMMENDATIONS3124 Neurology and psychiatryBrain Ischemia0302 clinical medicineMedicineProspective StudiesRegistries10064 Neuroscience Center ZurichProspective cohort studyIntersectoral CollaborationThrombectomyRISKEndovascular ProceduresThrombolysisGeneral Medicine3. Good healthStrokeCohortrevascularizationAdministration IntravenousINTRAVENOUS THROMBOLYSISthrombolysismedicine.medical_specialtyMEDLINE610 Medicine & healthRevascularizationfunctional outcome; registry; revascularization; stroke; thrombectomy; thrombolysisCLASSIFICATIONfunctional outcomePOOLED ANALYSIS03 medical and health sciencesALTEPLASEFibrinolytic AgentsHumansMETAANALYSISbusiness.industryStatin treatment10040 Clinic for NeurologyIV THROMBOLYSISSYMPTOMATIC INTRACEREBRAL HEMORRHAGE3121 General medicine internal medicine and other clinical medicineIschemic strokeEmergency medicine570 Life sciences; biologyObservational studybusiness030217 neurology & neurosurgeryBMJ open
researchProduct

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

2015

The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens, including dendritic cell-based vaccines, checkpoint-blocking therapies, and adoptive T-cell transfer, researchers have started to focus on the overall immunobiology of neoplastic cells. It is now clear that cancer cells can succumb to some anticancer therapies by undergoing a peculiar form of cell death that is characterized by an increased immunogenic potential, owing to the emission of the so-called "damage-associated molecular patterns" (DAMPs). The emission of DAMPs and other immunostimulatory factors by…

medicine.medical_treatmentAPOPTOTIC CALRETICULIN EXPOSUREanti-tumor immunityimmunogenicityPHOTODYNAMIC THERAPY0302 clinical medicinetranslational medicineoncoimmunologyImmunology and AllergyCytotoxic T cellMedicineAnti-tumor immunity; Immunogenicity; Immunotherapy; Molecular medicine; Oncoimmunology; Patient prognosis; Translational medicine; Immunology; Immunology and Allergy0303 health sciencesanti-tumor immunity; immunogenicity; immunotherapy; molecular medicine; oncoimmunology; patient prognosis; translational medicineRIBOSOMAL-PROTEIN DIMERClassificationddc:3. Good health030220 oncology & carcinogenesisImmunogenic cell deathMolecular MedicineimmunotherapyACTIVATING POLYPEPTIDE-IIHIGH HYDROSTATIC-PRESSURElcsh:Immunologic diseases. AllergyANTICANCER IMMUNE-RESPONSESImmunology3122 Cancers610 Medicine & healthpatient prognosis03 medical and health sciencesImmune systemHUMAN TUMOR-CELLSFORMYL PEPTIDE RECEPTORS030304 developmental biologybusiness.industryTranslational medicineBiology and Life SciencesCYTOTOXIC T-LYMPHOCYTESImmunotherapyDendritic cellMolecular medicineNEGATIVE BREAST-CANCERImmunologyCancer cellmolecular dicine3111 Biomedicinebusinesslcsh:RC581-607Frontiers in Immunology
researchProduct

The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes.

1998

The disappointing clinical results of cancer immunotherapy of the past few decades have not diminished the optimism about the potential of the new generation of immunotherapeutic strategies towards treatment of malignant disease. Tremendous progress has been made over recent years in unveiling the molecular basis of antigen presentation and recognition by cytotoxic T lymphocytes (CTL). The molecular concepts that have emerged from these studies have led to the design of novel anticancer vaccines and CTL-based immunotherapeutics. This review is to highlight the current molecular insights of antigen presentation and CTL recognition/activation, and their impact on the rational design of therap…

medicine.medical_treatmentAntigen presentationMolecular Sequence Datachemical and pharmacologic phenomenaCancer VaccinesImmune systemCancer immunotherapyNeoplasmsDrug DiscoverymedicineCytotoxic T cellAnimalsHumansAmino Acid SequenceGenetics (clinical)Antigen Presentationbusiness.industryImmunotherapyT lymphocyteMolecular medicineCTL*ImmunologyMolecular MedicineImmunotherapybusinessT-Lymphocytes CytotoxicJournal of molecular medicine (Berlin, Germany)
researchProduct